BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6294903)

  • 1. Some chemical aspects of labeling human fibrinogen with 99m-technetium.
    Kirstein M; Fridrich R; Seiler H
    Thromb Res; 1982 Nov; 28(3):351-60. PubMed ID: 6294903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation, radiolabeling with
    de Arcocha-Torres M; Quincoces G; Martínez-López AL; Erhard A; Collantes M; Martínez-Rodríguez I; Ecay M; Banzo I; Irache JM; Peñuelas I
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):225-232. PubMed ID: 32201272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits.
    Kowalsky RJ; Dalton DR
    Am J Hosp Pharm; 1981 Nov; 38(11):1722-6. PubMed ID: 7304626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, characterization and bioevaluation of technetium-99m labeled N-(2-Hydroxybenzyl)-2-amino-2-deoxy-D-glucose as a tumor imaging agent.
    Nadeem Q; Khan I; Javed M; Mahmood Z; Dar UK; Ali M; Hyder SW; Murad S
    Pak J Pharm Sci; 2013 Mar; 26(2):353-7. PubMed ID: 23455207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting the labeling of human fibrinogen with 99mTc in vitro.
    Lavie E; Shenberg C; Bitton M; Mechlis S
    Int J Appl Radiat Isot; 1984 Feb; 35(2):99-102. PubMed ID: 6706430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study on in vivo erythrocyte labeling with 99m Tc using stannous chloride].
    Hiraki T; Katayama M; Ando I; Ando A; Hisada K
    Kaku Igaku; 1982 Apr; 19(3):399-408. PubMed ID: 6290721
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of source and age of sodium pertechnetate Tc 99m on radiochemical purity of technetium Tc 99m exametazime.
    Millar AM
    Am J Hosp Pharm; 1993 Jan; 50(1):103-6. PubMed ID: 8381258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte labeling with technetium-99m tin colloids.
    Mock BH; English D
    J Nucl Med; 1987 Sep; 28(9):1471-7. PubMed ID: 3625299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro stability in human plasma of two different technetium-99m-fibrinogen compounds.
    Spicher E; Gieux B; Fridrich R
    Experientia; 1984 Jun; 40(6):543-4. PubMed ID: 6327361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m labeling of antibodies to cardiac myosin Fab and to human fibrinogen.
    Khaw BA; Strauss HW; Carvalho A; Locke E; Gold HK; Haber E
    J Nucl Med; 1982 Nov; 23(11):1011-9. PubMed ID: 7131084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A technique for the preparation of Tc-99m red blood cells for evaluation of gastrointestinal hemorrhage.
    Benedetto AR; Nusynowitz ML
    Clin Nucl Med; 1983 Apr; 8(4):160-2. PubMed ID: 6303670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (99m)Tc human IgG radiolabelled by HYNIC. Biodistribution and scintigraphy of experimentally induced inflammatory lesions in animal model.
    Karczmarczyk U; Markiewicz A; Mikołajczak R; Lisiak E; Bilski M; Pietrzykowski J; Michalik J
    Nucl Med Rev Cent East Eur; 2004; 7(2):107-12. PubMed ID: 15968595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Labeling of red blood cells with Tc-99m after oral administration of SnCl2: concise communication.
    Patel MC; Parab PB; Samuel AM; Ganatra RD
    J Nucl Med; 1979 Aug; 20(8):877-81. PubMed ID: 541736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of plasmid DNA by a Ginkgo biloba extract from the effects of stannous chloride and the action on the labeling of blood elements with technetium-99m.
    Moreno SR; Freitas RS; Rocha EK; Lima-Filho GL; Bernardo-Filho M
    Braz J Med Biol Res; 2004 Feb; 37(2):267-71. PubMed ID: 14762583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New efficient cell-labeling method with Tc-99m pertechnetate via neutral and lipid soluble Sn(II)--mercaptopyridine N-oxide complex and comparative evaluation with Tc-99m HMPAO labeled platelets.
    Dewanjee MK; Kapadvanjwala M; Dewanjee S; Ghafouripour AK; Serafini AN; Sfakianakis GN
    Prog Clin Biol Res; 1990; 355():1-9. PubMed ID: 2177894
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical application of spontaneous red blood cell labeling with Tc-99m sodium pertechnetate.
    Kaminaga T; Nishimura T; Hayashida K; Ishida Y; Hiroki M
    Clin Nucl Med; 1994 Oct; 19(10):895-7. PubMed ID: 7805326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Sn(II) ion concentration and heparin on technetium-99m red blood cell labeling.
    Rao SA; Knobel J; Collier BD; Isitman AT
    J Nucl Med; 1986 Jul; 27(7):1202-6. PubMed ID: 3014088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified method for the in vivo labeling of red blood cells with Tc-99m: concise communication.
    Callahan RJ; Froelich JW; McKusick KA; Leppo J; Strauss HW
    J Nucl Med; 1982 Apr; 23(4):315-8. PubMed ID: 6279801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gel-chromatographic analysis of 99mTc-labeled human serum albumin prepared with Sn(II) as the reductant.
    Dekker BG; Arts CJ; De Ligny CL
    Int J Appl Radiat Isot; 1982 Dec; 33(12):1351-7. PubMed ID: 6220978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m labeled mouse-spleen leukocytes: radiolabeling parameters--II.
    Dettman GL; Wilbur SM; Vandenburg BL
    Int J Appl Radiat Isot; 1980 Apr; 31(4):217-22. PubMed ID: 7380579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.